Additional file 1 of Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network—the ProneCOVID study
Creators: name: Le Terrier, Christophe
name: Sigaud, Florian
name: Lebbah, Said
name: Desmedt, Luc
name: Hajage, David
name: Guérin, Claude
name: Pugin, Jérôme
name: Primmaz, Steve
name: Terzi, Nicolas
Publisher: name: figshare
Year: 2022
Subjects: subject: Medicine
subject: Microbiology
subject: FOS: Biological sciences
subject: Biotechnology
subject: Immunology
subject: FOS: Clinical medicine
subject: 69999 Biological Sciences not elsewhere classified
subject: Cancer
subject: Science Policy

description: Additional file 1. Additional information about the baseline characteristics and the statistical analysis (file format in .docx). Additional Tables and Figures. Table S1. Distribution of patients per region included in this study according to their prone position status at Day-1. Table S2. Descriptive analysis of baseline population included in propensity score analysis and complete case population. Table S3. Descriptive analysis of baseline characteristics before and after weighted-propensity score analysis. Fig. S1. Adjustment quality before and after propensity score analysis. Table S4. Descriptive subgroup analysis of baseline population with PaO2/FiO2 ratio &lt; 150 mmHg at Day-1 included in propensity score analysis and complete case population. Table S5. Descriptive subgroup analysis of baseline population characteristics with PaO2/FiO2 ratio &lt; 150 mmHg at Day-1 before and after weighted-propensity score analysis. Fig. S2. Adjustment quality before and after propensity score analysis in the subgroup of patients with PaO2/FiO2 ratio &lt; 150 mmHg at Day-1. Fig. S3. a Kaplan–Meier curves according to prone status in ICU at Day-1 before weighting adjustment in complete case subgroup population with PaO2/FiO2 ratio &lt; 150 mmHg. b Kaplan–Meier curves according to prone status in ICU at Day-1 after weighting adjustment in complete case subgroup population with PaO2/FiO2 &lt; 150 mmHg. Fig. S4. a Forest plot: Hazard Ratio according to prone status in ICU at Day-1 before and after weighting in complete case subgroup population with PaO2/FiO2 ratio &lt; 150 mmHg. b Hazard Ratio according to prone status in ICU at Day-1 before and after weighting in baseline subgroup population with PaO2/FiO2 ratio &lt; 150 mmHg. Table S6. Descriptive subgroup analysis of baseline population with PaO2/FiO2 ratio &gt; 150 mmHg included in propensity score analysis and complete case population. Table S7. Descriptive subgroup analysis of baseline population characteristics with PaO2/FiO2 ratio &gt; 150 mmHg at Day-1 before and after weighted-propensity score analysis. Fig. S5. Adjustment quality before and after propensity score analysis in the subgroup of patients with PaO2/FiO2 ratio &gt; 150 mmHg at Day-1. Fig. S6. a Kaplan–Meier curves according to prone status in ICU at Day-1 before weighting adjustment in complete case subgroup population with PaO2/FiO2 ratio &gt; 150 mmHg. b Kaplan–Meier curves according to prone status in ICU at Day-1 after weighting adjustment in complete case subgroup population with PaO2/FiO2 ratio &gt; 150 mmHg. Fig. S7. a Forest plot: Hazard Ratio according to prone status in ICU at Day-1 before and after weighting in complete case subgroup population with PaO2/FiO2 ratio &gt; 150 mmHg. b Hazard Ratio according to prone status in ICU at Day-1 before and after weighting in baseline subgroup population with PaO2/FiO2 ratio &gt; 150 mmHg.